Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cyient Limited Capital/Financing Update 2026

Apr 30, 2026

60361_rns_2026-04-30_44ac72ae-9ebe-4b5b-acbd-ec5f0c3f6e78.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

CYIENT

Date: 30 April 2026

BSE Limited
PJ towers, 25th Floor
Dalal Street,
Mumbai – 400001
Scrip Code: 532175

National Stock Exchange of India Limited
Exchange Plaza
Bandra Kurla Complex, Bandra East, Mumbai,
Maharashtra 400051
Scrip Code: CYIENT

Dear Sir/Madam,

Sub: Clarification regarding the outcome filed on 23 April 2026 - Proposal for buyback of equity shares

In continuation of our letter dated 23 April 2026 (Post Board Meeting Announcement), we inform you that, in the outcome disclosed by the Company in relation to the proposed buyback, it was stated that the Company has a class of securities "registered" under Section 12 of the Securities Exchange Act of 1934 in the United States. While the securities are not registered securities, the requirement for the approval of U.S. Securities and Exchange Commission (SEC) as mentioned in the Post Board Meeting Announcement, continues and remains unchanged. Accordingly, the relevant portion of the intimation, as corrected, is reproduced below:

The Board also noted that, given the shareholding of US residents in the Company’s Equity Shares, it is necessary for the Company to seek and obtain exemptive relief from the U.S. Securities and Exchange Commission (SEC) on certain aspects of the tender offer procedures, due to conflicting regulatory requirements between Indian and U.S. laws for tender offer buybacks and the Company will be making application in this regard.

This is for your information and records.

Yours sincerely,

For Cyient Limited

Sudheendhra Putty
Company Secretary

Cyient Ltd. 4th Floor, A Wing, 11 Software
Units Layout, Madhapur
Hyderabad -500 081
India

CIN: L72200TG1991PLC013134
www.cyient.com
[email protected]
T +91 40 6764 1000
F +91 40 2311 0352